Stephan Oertel

1.8k total citations
30 papers, 1.2k citations indexed

About

Stephan Oertel is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Stephan Oertel has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 21 papers in Oncology and 10 papers in Genetics. Recurrent topics in Stephan Oertel's work include Viral-associated cancers and disorders (21 papers), Lymphoma Diagnosis and Treatment (21 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Stephan Oertel is often cited by papers focused on Viral-associated cancers and disorders (21 papers), Lymphoma Diagnosis and Treatment (21 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Stephan Oertel collaborates with scholars based in Germany, Switzerland and France. Stephan Oertel's co-authors include Hanno Riess, Ralf Ulrich Trappe, Ioannis Anagnostopoulos, Petra Reinke, Matthias Papp‐Váry, Bernd Dörken, Manfred Hummel, Sven Jonas, Véronique Leblond and Sylvain Choquet and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Stephan Oertel

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephan Oertel Germany 19 922 656 238 193 152 30 1.2k
RS Shapiro United States 7 886 1.0× 365 0.6× 378 1.6× 101 0.5× 196 1.3× 8 1.3k
Rosanna Scimè Italy 18 403 0.4× 271 0.4× 117 0.5× 212 1.1× 363 2.4× 51 1.2k
Riccardo Varaldo Italy 22 536 0.6× 169 0.3× 237 1.0× 249 1.3× 357 2.3× 56 1.5k
N Gratecos France 13 306 0.3× 241 0.4× 176 0.7× 191 1.0× 230 1.5× 46 1.2k
A. Grigg Australia 18 272 0.3× 141 0.2× 154 0.6× 179 0.9× 144 0.9× 37 825
F Silvestri Italy 17 332 0.4× 301 0.5× 168 0.7× 269 1.4× 123 0.8× 41 941
Nobuhiko Uoshima Japan 15 311 0.3× 178 0.3× 200 0.8× 153 0.8× 170 1.1× 58 839
Yasunori Ueda Japan 20 410 0.4× 174 0.3× 111 0.5× 272 1.4× 289 1.9× 115 1.6k
Andrea Assanelli Italy 18 263 0.3× 373 0.6× 69 0.3× 249 1.3× 455 3.0× 47 1.2k
Keiko Yumura‐Yagi Japan 18 332 0.4× 243 0.4× 55 0.2× 155 0.8× 343 2.3× 49 1.2k

Countries citing papers authored by Stephan Oertel

Since Specialization
Citations

This map shows the geographic impact of Stephan Oertel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Oertel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Oertel more than expected).

Fields of papers citing papers by Stephan Oertel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Oertel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Oertel. The network helps show where Stephan Oertel may publish in the future.

Co-authorship network of co-authors of Stephan Oertel

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Oertel. A scholar is included among the top collaborators of Stephan Oertel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Oertel. Stephan Oertel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Witzens‐Harig, Mathias, Robin Foà, Alice Di Rocco, et al.. (2014). Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study. Annals of Hematology. 93(10). 1717–1724. 23 indexed citations
2.
Walzer, Stefan, et al.. (2013). Microeconomic Surplus in Health Care: Applied Economic Theory in Health Care in Four European Countries. Frontiers in Pharmacology. 4. 17–17. 2 indexed citations
3.
Zimmermann, Heiner, Petra Reinke, R. Neuhaus, et al.. (2012). Burkitt post‐transplantation lymphoma in adult solid organ transplant recipients. Cancer. 118(19). 4715–4724. 22 indexed citations
4.
Leblond, Véronique, Kamel Laribi, Osman İlhan, et al.. (2012). Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).. Blood. 120(21). 2744–2744. 17 indexed citations
5.
6.
Sturm, Isrid, Joachim Oertel, Stephan Oertel, Jörg Westermann, & Antonio Pezzutto. (2008). Successful long-term monotherapy with rituximab in a patient with chronic lymphocytic leukemia of the B-cell-lineage: a case report. Journal of Medical Case Reports. 2(1). 275–275. 1 indexed citations
7.
Trappe, Ralf Ulrich, Sylvain Choquet, Stephan Oertel, et al.. (2007). Efficacy and safety of sequential treatment with rituximab and CHOP chemotherapy in B-cell PTLD: Results of a prospective international phase II study. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
8.
Babel, Nina, Athanasios Vergopoulos, Ralf Ulrich Trappe, et al.. (2007). Evidence for Genetic Susceptibility Towards Development of Posttransplant Lymphoproliferative Disorder in Solid Organ Recipients. Transplantation. 84(3). 387–391. 36 indexed citations
9.
Trappe, Ralf Ulrich, Sylvain Choquet, Petra Reinke, et al.. (2007). Salvage Therapy for Relapsed Posttransplant Lymphoproliferative Disorders (PTLD) With a Second Progression of PTLD After Upfront Chemotherapy: The Role of Single-Agent Rituximab. Transplantation. 84(12). 1708–1712. 30 indexed citations
10.
Choquet, Sylvain, Stephan Oertel, Véronique Leblond, et al.. (2007). Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution. Annals of Hematology. 86(8). 599–607. 101 indexed citations
11.
Trappe, Ralf Ulrich, Hanno Riess, Nina Babel, et al.. (2007). Salvage Chemotherapy for Refractory and Relapsed Posttransplant Lymphoproliferative Disorders (PTLD) After Treatment With Single-Agent Rituximab. Transplantation. 83(7). 912–918. 47 indexed citations
12.
Oertel, Stephan, Ralf Ulrich Trappe, Kristin Zeidler, et al.. (2006). Epstein–Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course. Annals of Hematology. 85(7). 478–484. 30 indexed citations
13.
Subklewe, Marion, Sylvain Choquet, Véronique Leblond, et al.. (2006). Association of Human Leukocyte Antigen Haplotypes with Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation. Transplantation. 82(8). 1093–1100. 41 indexed citations
14.
Oertel, Stephan, Erik A.M. Verschuuren, Petra Reinke, et al.. (2005). Effect of Anti‐CD 20 Antibody Rituximab in Patients with Post‐Transplant Lymphoproliferative Disorder (PTLD). American Journal of Transplantation. 5(12). 2901–2906. 184 indexed citations
15.
Oertel, Stephan, Matthias Papp‐Váry, Ioannis Anagnostopoulos, et al.. (2003). Salvage chemotherapy for refractory or relapsed post‐transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide. British Journal of Haematology. 123(5). 830–835. 29 indexed citations
16.
Oertel, Stephan & Hanno Riess. (2002). Antiviral Treatment of Epstein-Barr Virus-Associated Lymphoproliferations. Recent results in cancer research. 159. 89–95. 25 indexed citations
17.
Oertel, Stephan & Hanno Riess. (2002). Immunosurveillance, Immunodeficiency and Lymphoproliferations. Recent results in cancer research. 1–8. 31 indexed citations
18.
Oertel, Stephan & Hanno Riess. (2002). Immunosurveillance, Immunodeficiencies and Lymphoproliferations. Recent results in cancer research. 159. 1–8. 31 indexed citations
19.
Oertel, Stephan, Ioannis Anagnostopoulos, Wolf O. Bechstein, H Liehr, & Hanno Riess. (2000). TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER WITH THE ANTI-CD20 MONOCLONAL ANTIBODY RITUXIMAB ALONE IN AN ADULT AFTER LIVER TRANSPLANTATION. Transplantation. 69(3). 430–432. 48 indexed citations
20.
Oertel, Stephan, Markus Ruhnke, Ioannis Anagnostopoulos, et al.. (1999). TREATMENT OF EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER WITH FOSCARNET ALONE IN AN ADULT AFTER SIMULTANEOUS HEART AND RENAL TRANSPLANTATION. Transplantation. 67(5). 765–767. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by RS Shapiro Breakdown of academic impact, for papers by Rosanna Scimè Breakdown of academic impact, for papers by Riccardo Varaldo Breakdown of academic impact, for papers by N Gratecos Breakdown of academic impact, for papers by A. Grigg Breakdown of academic impact, for papers by F Silvestri Breakdown of academic impact, for papers by Nobuhiko Uoshima Breakdown of academic impact, for papers by Yasunori Ueda Breakdown of academic impact, for papers by Andrea Assanelli Breakdown of academic impact, for papers by Keiko Yumura‐Yagi
Rankless by CCL
2026